"tenofovir" Pill Images
The following drug pill images match your search criteria.

L 24
Emtricitabine and Tenofovir Disoproxil Fumarate
- Strength
- 200 mg / 300 mg
- Imprint
- L 24
- Color
- White
- Shape
- Capsule/Oblong

LA49
Emtricitabine and Tenofovir Disoproxil Fumarate
- Strength
- 200 mg / 300 mg
- Imprint
- LA49
- Color
- White
- Shape
- Capsule/Oblong

H 124
Emtricitabine and Tenofovir Disoproxil Fumarate
- Strength
- 200 mg / 300 mg
- Imprint
- H 124
- Color
- White
- Shape
- Capsule/Oblong

I 37
Emtricitabine and Tenofovir Disoproxil Fumarate
- Strength
- 200 mg / 300 mg
- Imprint
- I 37
- Color
- White
- Shape
- Capsule/Oblong

H 128
Efavirenz, Emtricitabine and Tenofovir Disoproxil Fumarate
- Strength
- 600 mg / 200 mg / 300 mg
- Imprint
- H 128
- Color
- White
- Shape
- Capsule/Oblong
Featured

Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Reviews & ratings

TV C75
Emtricitabine and Tenofovir Disoproxil Fumarate
- Strength
- 200 mg / 300 mg
- Imprint
- TV C75
- Color
- Blue
- Shape
- Capsule/Oblong

69 Y
Tenofovir Disoproxil Fumarate
- Strength
- 250 mg
- Imprint
- 69 Y
- Color
- White
- Shape
- Capsule/Oblong

AC24
Emtricitabine and Tenofovir Disoproxil Fumarate
- Strength
- 200 mg / 300 mg
- Imprint
- AC24
- Color
- White
- Shape
- Capsule/Oblong

1367
Emtricitabine and Tenofovir Disoproxil Fumarate
- Strength
- 200 mg / 300 mg
- Imprint
- 1367
- Color
- White
- Shape
- Capsule/Oblong

CL81
Efavirenz, Emtricitabine and Tenofovir Disoproxil Fumarate
- Strength
- 600 mg / 200 mg / 300 mg
- Imprint
- CL81
- Color
- Pink
- Shape
- Capsule/Oblong

H 123

M ET 23
Emtricitabine and Tenofovir Disoproxil Fumarate
- Strength
- 200 mg / 300 mg
- Imprint
- M ET 23
- Color
- Green
- Shape
- Capsule/Oblong
1 / 2
Loading
L65
Efavirenz, Lamivudine and Tenofovir Disoproxil Fumarate
- Strength
- 600 mg / 300 mg / 300 mg
- Imprint
- L65
- Color
- White
- Shape
- Capsule/Oblong
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.